Fennec Pharmaceuticals Inc. (TSX:FRX)
Canada · Delayed Price · Currency is CAD 10.50
-0.04 (-0.33%)
Feb 11, 2026, 12:12 PM EST
Fennec Pharmaceuticals Market Cap
Fennec Pharmaceuticals has a market cap or net worth of CAD 360.16 million as of February 11, 2026. Its market cap has increased by 39.17% in one year.
Market Cap
360.16M
Enterprise Value
356.68M
Revenue
54.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.50
Market Cap Chart
Since November 12, 2004, Fennec Pharmaceuticals's market cap has increased from 89.84M to 360.16M, an increase of 300.91%. That is a compound annual growth rate of 6.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 360.16M | -0.12% |
| Dec 31, 2025 | 360.58M | 44.35% |
| Dec 31, 2024 | 249.80M | -36.88% |
| Dec 29, 2023 | 395.77M | 15.99% |
| Dec 30, 2022 | 341.20M | 135.62% |
| Dec 31, 2021 | 144.81M | -40.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.01B |
| Eupraxia Pharmaceuticals | 580.43M |
| NervGen Pharma | 426.12M |
| Satellos Bioscience | 319.63M |
| Helix BioPharma | 139.77M |
| ME Therapeutics Holdings | 68.21M |
| Medicenna Therapeutics | 66.74M |
| Sharp Therapeutics | 66.17M |